Bioinformatic analysis identifies key molecules in castration resistance prostate cancer, suggesting future research directions.
Background: Castration resistance prostate cancer (CRPC) is a complex tumor associated with high mortality. To discover key molecules in CRPC, we dissected the data of CRPC based on arrays by bioinformatic analysis. Methods: The gene expression profiling datasets of prostate cancer were analyzed online. The Database for Annotation, Visualization, and Integrated Discovery (DAVID, https://david.ncifcrf.gov/) was used to perform Gene Ontology (GO) functional and KEGG pathway enrichment analyses. Molecular Complex Detection (MCODE) in Cytoscape software (Cytoscape_v3.6.1) was applied to screen hub genes. Gene expression data were obtained from the ONCOMINE website (https://www.oncomine.org/). The gene expression and survival data were downloaded and analyzed. Results: 4 datasets (GSE104935, GSE120005, GSE78201, and GSE21887) were included for analysis. The 15 overlap up-regulated genes and 27 overlap down-regulated genes were identified and analyzed by DAVID. 11 proteins corresponding to genes (ELOVL6, ABCA1, FOXO3, and TNRC6B; ALDH1A3, OSBPL8, ACSL3, SLC45A3, KLK2, FKBP5, and PMEPA1) were identified to be key genes. Gene expression suggested OSBPL8, PMEPA1, and SLC45A3 were different expressed in CRPC patients, these genes were also associated with survival. Conclusions: OSBPL8, PMEPA1, and SLC45A3 were involved with CRPC. These candidate genes were rarely researched, their functions needed experiments in vivo and in vitro to verify.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: